Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 976 AL 990

Targeting the mTOR signaling network for Alzheimer's disease therapy

Wang C, Yu JT, Miao D, Wu ZC, Tan MS, Tan L.

Mol Neurobiol. 2014 Feb;49(1):120-35. doi: 10.1007/s12035-013-8505-8. Epub 2013 Jul 14.

Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?

Ahmed T, Gilani AH.

Phytother Res. 2014 Apr;28(4):517-25. doi: 10.1002/ptr.5030. Epub 2013 Jul 19.

Therapeutics of Alzheimer's disease: Past, present and future

Anand R, Gill KD, Mahdi AA.

Neuropharmacology. 2014 Jan;76 Pt A:27-50. doi: 10.1016/j.neuropharm.2013.07.004. Epub 2013 Jul 25.

β-Amyloid precursor protein: function in stem cell development and Alzheimer's disease brain

Small DH, Hu Y, Bolós M, Dawkins E, Foa L, Young KM.

Neurodegener Dis. 2014;13(2-3):96-8. doi: 10.1159/000353686. Epub 2013 Aug 7.

How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?

Gauthier S, Leuzy A, Rosa-Neto P.

Neurodegener Dis. 2014;13(2-3):197-9. doi: 10.1159/000353748. Epub 2013 Aug 7.

Comparing atomistic molecular mechanics force fields for a difficult target: a case study on the Alzheimer's amyloid β-peptide

Gerben SR, Lemkul JA, Brown AM, Bevan DR.

J Biomol Struct Dyn. 2014;32(11):1817-32. doi: 10.1080/07391102.2013.838518. Epub 2013 Sep 13.

Tau immunotherapy and imaging

Sigurdsson EM.

Neurodegener Dis. 2014;13(2-3):103-6. doi: 10.1159/000354491. Epub 2013 Sep 11.

Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise

Irwin RW, Brinton RD.

Prog Neurobiol. 2014 Feb;113:40-55. doi: 10.1016/j.pneurobio.2013.08.004. Epub 2013 Sep 14.

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation

Barone E, Di Domenico F, Mancuso C, Butterfield DA.

Neurobiol Dis. 2014 Feb;62:144-59. doi: 10.1016/j.nbd.2013.09.018. Epub 2013 Oct 2.

New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease

Medina M, Avila J.

Expert Opin Ther Targets. 2014 Jan;18(1):69-77. doi: 10.1517/14728222.2013.843670. Epub 2013 Oct 8.

Intervention strategies for spatial orientation disorders in dementia: a selective review

Caffò AO, Hoogeveen F, Groenendaal M, Perilli AV, Picucci L, Lancioni GE, Bosco A.

Dev Neurorehabil. 2014 Jun;17(3):200-9. doi: 10.3109/17518423.2012.749951. Epub 2013 Oct 8.

Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline

Hennebelle M, Plourde M, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P, Cunnane SC.

Proc Nutr Soc. 2014 Feb;73(1):80-6. doi: 10.1017/S0029665113003625. Epub 2013 Oct 9.

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T.

Alzheimers Dement. 2014 Jul;10(4):485-502. doi: 10.1016/j.jalz.2013.05.1771. Epub 2013 Oct 19.

Research status of the regulation of miRNA on BACE1

Deng Y, Ding Y, Hou D.

Int J Neurosci. 2014 Jul;124(7):474-7. doi: 10.3109/00207454.2013.858249. Epub 2013 Nov 21.

The therapeutic effects of human adipose-derived stem cells in Alzheimer's disease mouse models

Chang KA, Kim HJ, Joo Y, Ha S, Suh YH.

Neurodegener Dis. 2014;13(2-3):99-102. doi: 10.1159/000355261. Epub 2013 Oct 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias